Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 26, 2019
Hyaluronan-mediated motility receptor confers resistance to chemotherapy <i>via</i> TGFβ/Smad2-induced epithelial-mesenchymal transition in gastric cancerHuizhong Zhang, Liangliang Ren, Ya Ding, et al.
Frontiers in Molecular Biosciences|May 24, 2021
Identification of a Hypoxia-Related Signature for Predicting Prognosis and the Immune Microenvironment in Bladder CancerMinxiao Jiang, Liangliang Ren, Yuanlei Chen, et al.
Journal of Proteome Research|July 12, 2022
A Cytological Atlas of the Human Liver Proteome from PROTEOME<sup>SKY</sup>-LIVER<sup>Hu</sup> 2.0, a Publicly Available DatabaseYuanxiang Lao, Yanyan Li, Wei Wang, et al.
Molecules (Basel, Switzerland)|January 25, 2025
Investigation on the Hydrate Blockage Avoidance Performance of Two Anti-Agglomerants and Their Mixture with PVPSunan Wang, Litao Chen, Lei Guo, et al.
Scientific Reports|April 5, 2024
Proteomic analysis of DEN and CCl<sub>4</sub>-induced hepatocellular carcinoma mouse modelQian Zhang, Yuhui Liu, Liangliang Ren, et al.
Molecular & Cellular Proteomics : MCP|February 24, 2018
In Vivo Phosphoproteome Analysis Reveals Kinome Reprogramming in Hepatocellular CarcinomaLiangliang Ren, Chaoying Li, Youliang Wang, et al.
Polymers|July 27, 2024
Current Status and Development Trend of Research on Polymer-Based Kinetic Inhibitors for Natural Gas HydratesShujie Liu, Sunan Wang, Jiansheng Luo, et al.
Journal of Proteome Research|April 11, 2014
Discovery of novel genes and gene isoforms by integrating transcriptomic and proteomic profiling from mouse liverPeng Wu, Hongyu Zhang, Weiran Lin, et al.
International Journal of Surgery (London, England)|August 2, 2024
Global burden and trends in pre- and post-menopausal gynecological cancer from 1990 to 2019, with projections to 2040: a cross-sectional studyYuanhao Liang, Xingzhu Dai, Jiaqing Chen, et al.
Investigational New Drugs|May 5, 2020
Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory studyLing Li, Fei Kong, Lei Zhang, et al.
Pageof 6